share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Christopher

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Christopher

Recursion Pharmaceuticals | 4:持股變動聲明-高管 Gibson Christopher
美股sec公告 ·  07/12 18:58
Moomoo AI 已提取核心訊息
Recursion Pharmaceuticals, Inc. CEO Christopher Gibson completed a series of transactions involving the company's Class A Common Stock on July 10 and July 11, 2024. Gibson sold a total of 75,000 shares through open market or private sales at prices ranging from $7.47 to $7.48 per share, resulting in a total market value of $747,500. Additionally, Gibson reported acquiring 100,000 shares at no cost, which is typically indicative of stock grants. After these transactions, Gibson's direct holdings in Recursion Pharmaceuticals amounted to 758,738 shares. The transactions were reported as completed and were conducted over a two-day period.
Recursion Pharmaceuticals, Inc. CEO Christopher Gibson completed a series of transactions involving the company's Class A Common Stock on July 10 and July 11, 2024. Gibson sold a total of 75,000 shares through open market or private sales at prices ranging from $7.47 to $7.48 per share, resulting in a total market value of $747,500. Additionally, Gibson reported acquiring 100,000 shares at no cost, which is typically indicative of stock grants. After these transactions, Gibson's direct holdings in Recursion Pharmaceuticals amounted to 758,738 shares. The transactions were reported as completed and were conducted over a two-day period.
2024年7月10日和11日,Recursion Pharmaceuticals的首席執行官Christopher Gibson完成了一系列公司A類普通股的交易。Gibson通過公開市場或私人銷售以每股7.47美元至7.48美元的價格總計出售了75,000股,市值總計爲747,500美元。此外,Gibson報告稱獲得了100,000股免費股票,這通常是股票授予的標誌。在這些交易之後,Gibson在Recursion Pharmaceuticals的直接持股總數爲758,738股。這些交易已經完成,並在兩天的時間內進行。
2024年7月10日和11日,Recursion Pharmaceuticals的首席執行官Christopher Gibson完成了一系列公司A類普通股的交易。Gibson通過公開市場或私人銷售以每股7.47美元至7.48美元的價格總計出售了75,000股,市值總計爲747,500美元。此外,Gibson報告稱獲得了100,000股免費股票,這通常是股票授予的標誌。在這些交易之後,Gibson在Recursion Pharmaceuticals的直接持股總數爲758,738股。這些交易已經完成,並在兩天的時間內進行。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息